Wikipedia -WSS

Wikipedia

author：focus 2025-09-28 00:48:46 - browse：4

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Alkermes shareholders re
Next article： How dance can help nurses traumatized by Covid

WSS

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

Google and Epic fight stronger regulation of AI in health care

Does Paxlovid work in people vaccinated against Covid

Detailed data confirm benefits, risks of Eli Lilly's Alzheimer's drug

focus

Wikipedia

focus

How to save PrEP access — and even expand it

JPM pitch from hospitals? Revenue streams outside of patient care

What does generative AI mean for health care? We asked experts

Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

Duchenne breakthrough therapy leaves behind pioneering families

Google and Epic fight stronger regulation of AI in health care

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Custom gene therapy hints at new path for rare disease treatments

Dobbs anniversary: the lost opportunity of abortion as health care

Fauci's latest grilling in Congress: 9 hours, behind closed doors

hotspot

Ascension's ugly legal battle over care for poor patients in Texas

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Custom gene therapy hints at new path for rare disease treatments

In early work, researchers turn to CRISPR to treat Alzheimer's

STAT Virtual Event: JPM Recap, Live!

A public scorecard can help hold safety

entertainment

Wikipedia

Wikipedia

Wikipedia